Collaboration makes AI models trained on over $1 billion in Lilly research data accessible directly in scientists' workflows.
Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...
The first command center for scientific AI, bringing agents and models to every scientist SAN FRANCISCO, Oct. 7, 2025 /PRNewswire/ -- Benchling AI launches today, giving scientists a command center to ...
After picking up $200 million just over six months ago, Benchling isn’t sitting still. The cloud-based R&D platform developer collected another $100 million to help power its global expansion plans.
Nearly half (44%) of top 50 biopharma companies are now involved in RNA work sparking new demand for tools purpose built for the full spectrum of RNA R&D SAN FRANCISCO, Sept. 7, 2022 /PRNewswire/ -- ...
SAN FRANCISCO and BOSTON, May 7, 2025 /PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling ...
After collecting $300 million across two venture capital rounds last year, R&D cloud software developer Benchling is starting to spend some of that cash by making its first acquisition. The company ...
Email and a smarter notebook might be enough for handling communication for projects or experiments inside a team in a lab in some university basement. But when you have around 200 scientists working ...
In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software for managing life sciences research, was able to nab ...
SAN FRANCISCO--(BUSINESS WIRE)--Today Benchling, the data management and collaboration platform built to advance life sciences research, announced it has closed $14.5M in Series B funding. The round ...
Nearly half (44%) of top 50 biopharma companies are now involved in RNA work sparking new demand for tools purpose built for the full spectrum of RNA R&D Following the successful deployment of RNA ...